SCHEMBL24596434

SCHEMBL24596434

c1ccc2nc(-c3cccc4sc5ccccc5c34)cnc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.42
▸ RAB9A P51151 6/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ MAPK10 P53779 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ HSP90AB1 P08238 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ BCHE P06276 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15590925 0.85 BCHE (0.44) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL24596660 0.82 ALOX5 (0.43) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL22113592 0.81 NPC1 (0.43) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL15590919 0.81 AR (0.46) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL25462036 0.80 NPC1 (0.40) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL24266233 0.80 CYP1A2 (0.54) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL22113628 0.79 NPC1 (0.39) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL22113857 0.79 NPC1 (0.40) NPC1RAB9AALDH1A1SMN1; SMN2HPGD
SCHEMBL22113816 0.78 NPC1 (0.43) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL15590924 0.77 CYP1A2 (0.45) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220216433-A1 ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220216433-A1 ELECTROLUMINESCENT DEVICE EML4, EMC2, L1CAM NPC1 3839/4885RAB9A 1587/4885KDM4E 1502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback